Skull base surgery addresses disorders at the complex floor of the cranial cavity, where critical cranial nerves and major blood vessels exit the brain. The primary goal of treatment is to safely remove pathological lesions, such as pituitary adenomas, meningiomas, and vestibular schwannomas, while protecting neurological function and vital vascular pathways.

Surgical care falls under the combined disciplines of Neurosurgery, Otolaryngology (ENT), and Head and Neck Surgical Oncology. Modern surgical mechanisms rely on precise image guidance, intraoperative neurophysiological monitoring, and micro-reconstructive techniques—such as vascularized tissue flaps—to ensure complete separation between the cranial cavity and the nasal or pharyngeal corridors.

Skull base surgery involves precise, multi-step surgical workflows tailored to the lesion's specific location and type.

1. Anesthesia and Patient Positioning: The patient is placed under general endotracheal anesthesia. Head fixators maintain rigid cranial stability. Continuous intraoperative neurophysiological monitoring (IONM) electrodes are placed to track cranial nerve function.

2. Image Guidance Registration: Intraoperative stereotactic navigation systems are calibrated using preoperative CT and MRI scans to provide real-time 3D anatomical tracking throughout the operation.

3. Surgical Access and Approach:
- Endoscopic Endonasal Approach (EEA): ENT and neurosurgical teams pass rigid 0-degree and 30-degree high-definition endoscopes through the nostrils. Turbinates are reflected, and a sphenoidotomy or ethmoidotomy is performed to expose the bony floor of the cranial fossa.
- Transcranial Approach: A neurosurgeon creates a surgical scalp incision and removes a small section of cranial bone (craniotomy) above or behind the ear, opening the dura mater to access deep brain regions.

4. Tumor Resection: Using micro-dissecting instruments, ultrasonic aspirators, and bipolar electrocautery, the surgical team carefully separates the tumor tissue from adjacent cranial nerves, brain parenchyma, and blood vessels.

5. Skull Base Reconstruction: If the dura or bony skull base is breached, a multi-layer reconstruction is performed using mucosal flaps (e.g., vascularized nasoseptal flap), fascia lata, abdominal fat grafts, or synthetic dural substitutes, secured with tissue glues.

6. Closure and Recovery Transition: Incisions are sutured, bone flaps are reattached with titanium mini-plates (in open craniotomy), and nasal packing or temporary lumbar drains are placed if clinically indicated.

Clinical evidence demonstrates several key advantages associated with modern skull base surgery techniques:

• Neurological Preservation: Targeted surgical corridors reduce the need for brain retraction, minimizing the risk of postoperative cerebral edema or neurological deficits (North American Skull Base Society [NASBS], 2020).
• High Tumor Control Rates: Complete or near-complete surgical resection provides durable local control for benign lesions and extends progression-free survival in malignant disease (NCCN Guidelines, 2023).
• Minimally Invasive Options: Endoscopic endonasal techniques avoid visible facial or cranial incisions, reducing postoperative pain and length of hospital stay (Kassam et al., 2005).
• Preservation of Visual Function: Early decompression of the optic chiasm in pituitary and suprasellar tumors yields high rates of visual field improvement (EANO Guidelines, 2021).
• Effective Defect Closure: Advanced vascularized flap reconstruction techniques have reduced postoperative CSF leak rates to under 5% across major clinical centers (Zanation et al., 2011).

Recovery following skull base surgery occurs in distinct physical phases over several weeks to months. Immediately post-surgery, patients are monitored closely in an intensive care setting for 24 to 48 hours to manage blood pressure, assess neurological function, and evaluate fluid-electrolyte balance (such as sodium regulation by the pituitary gland).

During the first 1 to 2 weeks, nasal packing or splints (if an endoscopic approach was used) are managed, and strict precautions are enforced: no blowing the nose, heavy lifting, or straining, to avoid compromising the reconstructed skull base. Patients usually return to light activities within 4 to 6 weeks. Complete internal tissue healing and full neurological recovery may take 3 to 6 months, supported by routine follow-up MRI scans, endocrine panels, and endoscopic examinations.

Skull base surgery addresses a broad range of neoplastic, vascular, and congenital conditions located at the base of the skull, including:

• Pituitary adenomas (functioning and non-functioning tumors of the pituitary gland)
• Meningiomas (benign tumors arising from the meningeal lining of the anterior, middle, or posterior cranial fossa)
• Vestibular schwannomas (acoustic neuromas affecting the eighth cranial nerve)
• Chordomas and chondrosarcomas (rare, slow-growing malignant tumors of the skull base bone)
• Craniopharyngiomas (cystic lesions located near the pituitary stalk and optic chiasm)
• Rathke cleft cysts and epidermoid cysts
• Spontaneous or traumatic cerebrospinal fluid (CSF) rhinorrhea and encephalocele defects
• Olfactory neuroblastomas (esthesioneuroblastomas) and sinonasal malignancies
• Trigeminal schwannomas and vascular compression syndromes (e.g., trigeminal neuralgia)

Preoperative preparation for skull base surgery requires rigorous multidisciplinary evaluation and physiological optimization.

1. Diagnostic Imaging: High-resolution contrast-enhanced MRI (1.5T or 3T) and fine-cut CT scans with vascular angiography are performed to map tumor boundaries and vascular supply.

2. Multi-Specialty Consultations: Evaluation by a neurosurgeon, otolaryngologist, neuro-ophthalmologist (for visual field baseline), and endocrinologist (for pituitary baseline hormone evaluation).

3. Medication Management: Antiplatelet agents, anticoagulants, and nonsteroidal anti-inflammatory drugs (NSAIDs) are suspended 7–14 days before surgery under medical supervision. Hormone replacement therapy or stress-dose corticosteroids may be initiated.

4. Nasal and Airway Assessment: Preoperative nasal endoscopy is performed to assess nasal septum integrity and detect underlying sinonasal infections.

5. Patient Education: Instruction on strict postoperative precautions, including prohibition of nose blowing, coughing with a closed mouth, straining during bowel movements, or using straws, to prevent high-pressure air spikes from breaching skull base repairs.

Complications in skull base surgery depend on tumor location, patient health, and surgical approach.

1. Common, Mild Complications:
- Sinonasal congestion, crusting, and mild nasal discomfort
- Transient headache and low-grade post-craniotomy pain
- Temporary alteration or loss of smell (anosmia/hyposmia)
- Mild, self-limiting fatigue

2. Uncommon Complications:
- Cerebrospinal fluid (CSF) leak requiring bed rest, lumbar drainage, or surgical re-exploration
- Transient or permanent diabetes insipidus (fluid imbalance due to pituitary stalk manipulation)
- Cranial nerve dysfunction leading to facial weakness, diplopia (double vision), or swallowing difficulties (dysphagia)
- Localized wound or sinonasal infection

3. Rare, Severe Complications:
- Internal carotid artery injury or major arterial laceration leading to severe intraoperative hemorrhage
- Postoperative stroke or cerebral ischemia
- Meningitis or intracranial abscess secondary to persistent CSF leak
- Permanent visual loss or profound cranial nerve deficits
- Mortality (under 1-2% in major centers).

The patient clinical journey begins with comprehensive diagnostic imaging, including high-resolution magnetic resonance imaging (MRI) and computed tomography (CT) angiography, alongside multi-specialty evaluations by neurosurgeons, ENT surgeons, and endocrinologists. Patients undergo dedicated preoperative medical optimization and neuro-navigation planning.

On the day of surgery, general anesthesia is administered with continuous continuous intraoperative neurophysiological monitoring. The surgical team accesses the lesion using either an endoscopic endonasal approach through the nasal passages or an open transcranial craniotomy. Following tumor removal, multi-layer reconstruction of the skull base is performed to prevent a cerebrospinal fluid (CSF) leak. Recovery involves 1–2 days in an intensive care unit (ICU), followed by step-down monitoring, hormone tracking, gradual physical mobilization, and structured follow-up imaging over months to years.